Paying users zone. Data is covered by hidden.

  • Get to Bristol-Myers Squibb Co. for $17.99, or

  • get to entire website for at least 3 months from $49.99.

Visa Mastercard Maestro American Express Discover JCB    PayPal
Next
Microsoft Excel LibreOffice Calc

Bristol-Myers Squibb Co. (BMY)

Statement of Comprehensive Income

Difficulty: Beginner

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Bristol-Myers Squibb Co., Consolidated Statement of Comprehensive Income

USD $ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net earnings hidden hidden hidden hidden hidden
Derivatives qualifying as cash flow hedges hidden hidden hidden hidden hidden
Pension and postretirement benefits hidden hidden hidden hidden hidden
Available-for-sale securities hidden hidden hidden hidden hidden
Foreign currency translation hidden hidden hidden hidden hidden
Other comprehensive income (loss) hidden hidden hidden hidden hidden
Comprehensive income hidden hidden hidden hidden hidden
Comprehensive (income) loss attributable to noncontrolling interest hidden hidden hidden hidden hidden
Comprehensive income attributable to BMS hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).

Item Description The company
Net earnings attributable to BMS The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Bristol-Myers Squibb Co.’s net earnings attributable to BMS declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.
Comprehensive income attributable to BMS Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Bristol-Myers Squibb Co.’s comprehensive income attributable to BMS declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.